Ternary Tx Managed by: Oliver Sexton
2 known investors
Find your way into Ternary Tx Managed by: Oliver Sexton
418 people in our graph share verified history with the Ternary Tx Managed by: Oliver Sexton team — schools, employers, funds. One of them is your warm intro.
Sam Blackmanunlockedknows Chris Tame · together at GSK (overlapped)
×7knows the team · via GSK
×3knows the team · via UCL
knows the team · via Cardiff University / Prifysgol Caerdydd
Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.
Founders & leadership
CT
Chris TameinCEO & Co-FounderChris Tame is CEO and co-founder of Ternary, which develops AI-driven drug discovery technology. He has experience building machine learning products for drug design and target identification, with expertise in targeted protein degradation approaches.
AP
Andrew PottertoninCTO & Co-FounderAndrew Potterton is a structural bioinformatician with 10 years of industry experience who co-founded Ternary, an AI-driven drug discovery platform for targeted protein degradation.
Investors · 2
Frequently asked questions
- What does Ternary Tx Managed by: Oliver Sexton do?
- Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.
- Who founded Ternary Tx Managed by: Oliver Sexton?
- Ternary Tx Managed by: Oliver Sexton was founded by Chris Tame, Andrew Potterton.
- Who are Ternary Tx Managed by: Oliver Sexton's investors?
- Ternary Tx Managed by: Oliver Sexton's investors include Pace Ventures, UK Innovation & Science Seed Fund.